Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Science Translational Medicine|October 9, 2024
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivoJohn Misasi, Ronnie R Wei, Lingshu Wang, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primatesJuan I Moliva, Shayne F Andrew, Barbara J Flynn, et al.
Pageof 14